Entrectinib

ATC L01EX14 · 10 markets · 23 records

Entrectinib 10 markets · 23 records Forms

AU 4 records · 3 strengths

200 mgcapsuleRozlytrek+1ROZLYTREK entrectinib 200 mg hard capsule bottle also in US·ES·GB +4 unknown
100 mgcapsuleROZLYTREK entrectinib 200 mg hard capsule bottle also in US·ES·GB +4 unknown

Records without a stated strength · 1 Rozlytrek

US 3 records · 3 strengths

200 mgcapsuleRozlytrek also in AU·ES·GB +4
100 mgcapsuleRozlytrek also in AU·ES·GB +4
50 mgpelletRozlytrek

ES 3 records · 3 strengths

200 mgcapsuleRozlytrek also in AU·US·GB +4
100 mgcapsuleRozlytrek also in AU·US·GB +4
50 mgliquidRozlytrek

GB 2 records · 2 strengths

200 mgcapsuleRozlytrek also in AU·US·ES +4
100 mgcapsuleRozlytrek also in AU·US·ES +4

CA 2 records · 2 strengths

200 mgcapsuleRozlytrek also in AU·US·ES +4
100 mgcapsuleRozlytrek also in AU·US·ES +4

SG 2 records · 2 strengths

200 mgcapsuleRozlytrek 100mg hard capsules also in AU·US·ES +4
100 mgcapsuleRozlytrek 100mg hard capsules also in AU·US·ES +4

CN 2 records · 2 strengths

200 mgcapsule罗圣全恩曲替尼 also in AU·US·ES +4
100 mgcapsule罗圣全恩曲替尼 also in AU·US·ES +4

TW 2 records · 2 strengths

200 mgcapsuleRozlytrek 100mg hard capsules+1羅思克200毫克膠囊 also in AU·US·ES +4
100 mgcapsuleRozlytrek 100mg hard capsules+1羅思克100毫克膠囊 also in AU·US·ES +4

HK 2 records · 1 strengths

Records without a stated strength · 1 Rozlytrek

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Rozlytrek

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	CN	ES	TW	HK	EU
200 mg capsule	Rozlytrek	Rozlytrek	Rozlytrek	Rozlytrek ROZLYTREK entrectinib 200 mg hard capsule bottle	Rozlytrek 100mg hard capsules	罗圣全恩曲替尼	Rozlytrek	Rozlytrek 100mg hard capsules 羅思克200毫克膠囊	not recorded	not recorded
100 mg capsule	Rozlytrek	Rozlytrek	Rozlytrek	ROZLYTREK entrectinib 200 mg hard capsule bottle	Rozlytrek 100mg hard capsules	罗圣全恩曲替尼	Rozlytrek	Rozlytrek 100mg hard capsules 羅思克100毫克膠囊	not recorded	not recorded
50 mg liquid	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Rozlytrek	not recorded	not recorded	not recorded
50 mg pellet	Rozlytrek	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Rozlytrek	not recorded	not recorded	not recorded	not recorded	Rozlytrek	Rozlytrek

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in ES and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en ES que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 ES 有记录（未在本表显示）。另有 1 個規格/劑型僅在 ES 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.